SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022.
<h4>Introduction</h4>Most studies on risk factors for a SARS-CoV-2 infection were conducted in the pre-vaccination era with many non-pharmaceutical prevention measures in place. We investigated risk factors for symptomatic SARS-CoV-2 infections in vaccinated persons in a period with a va...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0311229 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841533108125433856 |
|---|---|
| author | Claudia Laarman Susan J Hahné Hester E de Melker Mirjam J Knol |
| author_facet | Claudia Laarman Susan J Hahné Hester E de Melker Mirjam J Knol |
| author_sort | Claudia Laarman |
| collection | DOAJ |
| description | <h4>Introduction</h4>Most studies on risk factors for a SARS-CoV-2 infection were conducted in the pre-vaccination era with many non-pharmaceutical prevention measures in place. We investigated risk factors for symptomatic SARS-CoV-2 infections in vaccinated persons in a period with a varying degree of prevention measures.<h4>Methods</h4>In a test-negative case control study among vaccinated adults attending community COVID-19 testing locations between June 1st 2021 till February 28th 2022, we compared symptomatic cases with symptomatic controls (to study risk factors specific for SARS-CoV-2) and with asymptomatic controls (to study risk factors that could apply to respiratory infections in general). We examined potential risk factors including household composition and mitigation behaviour by logistic regression, adjusting for age, sex, and week of testing.<h4>Results</h4>Risk factors for a positive SARS-CoV-2 test when symptomatic cases were compared to symptomatic controls were: having a household size of more than 4 (adjusted odds ratio: 1.47; 95% CI 1.14-1.92), being a healthcare worker (1.27;1.18-1.47), and visiting busy locations outside (1.49;1.19-1.87). When symptomatic cases were compared to asymptomatic controls, a household size of more than 4 members (1.71;1.25-2.33), living with children aged 0-12 (1.59;1.12-2.26), visiting busy locations outside (1.64;1.24-2.17) were independent risk factors for a positive SARS-CoV-2 test. Risk factors for separate periods and waves differed from the study period as a whole.<h4>Conclusion</h4>This study was conducted in a period with a varying degree of prevention measures. Among vaccinated individuals, we identified several SARS-CoV-2 specific risk factors and SARS-CoV-2 risk factors that could be more general for respiratory infections. For SARS-CoV-2 transmission more attention could be given to visiting busy outdoor locations, having a household size that consists of more than 4 persons, being a healthcare worker, and living with children aged 0-12. Risk factors varied with different phases in the pandemic, emphasizing the importance of repeated assessment of risk factors. |
| format | Article |
| id | doaj-art-9f5ab52af74a4eb9993868d3393836d9 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-9f5ab52af74a4eb9993868d3393836d92025-01-17T05:32:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031122910.1371/journal.pone.0311229SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022.Claudia LaarmanSusan J HahnéHester E de MelkerMirjam J Knol<h4>Introduction</h4>Most studies on risk factors for a SARS-CoV-2 infection were conducted in the pre-vaccination era with many non-pharmaceutical prevention measures in place. We investigated risk factors for symptomatic SARS-CoV-2 infections in vaccinated persons in a period with a varying degree of prevention measures.<h4>Methods</h4>In a test-negative case control study among vaccinated adults attending community COVID-19 testing locations between June 1st 2021 till February 28th 2022, we compared symptomatic cases with symptomatic controls (to study risk factors specific for SARS-CoV-2) and with asymptomatic controls (to study risk factors that could apply to respiratory infections in general). We examined potential risk factors including household composition and mitigation behaviour by logistic regression, adjusting for age, sex, and week of testing.<h4>Results</h4>Risk factors for a positive SARS-CoV-2 test when symptomatic cases were compared to symptomatic controls were: having a household size of more than 4 (adjusted odds ratio: 1.47; 95% CI 1.14-1.92), being a healthcare worker (1.27;1.18-1.47), and visiting busy locations outside (1.49;1.19-1.87). When symptomatic cases were compared to asymptomatic controls, a household size of more than 4 members (1.71;1.25-2.33), living with children aged 0-12 (1.59;1.12-2.26), visiting busy locations outside (1.64;1.24-2.17) were independent risk factors for a positive SARS-CoV-2 test. Risk factors for separate periods and waves differed from the study period as a whole.<h4>Conclusion</h4>This study was conducted in a period with a varying degree of prevention measures. Among vaccinated individuals, we identified several SARS-CoV-2 specific risk factors and SARS-CoV-2 risk factors that could be more general for respiratory infections. For SARS-CoV-2 transmission more attention could be given to visiting busy outdoor locations, having a household size that consists of more than 4 persons, being a healthcare worker, and living with children aged 0-12. Risk factors varied with different phases in the pandemic, emphasizing the importance of repeated assessment of risk factors.https://doi.org/10.1371/journal.pone.0311229 |
| spellingShingle | Claudia Laarman Susan J Hahné Hester E de Melker Mirjam J Knol SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. PLoS ONE |
| title | SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. |
| title_full | SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. |
| title_fullStr | SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. |
| title_full_unstemmed | SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. |
| title_short | SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. |
| title_sort | sars cov 2 risk factors among symptomatic vaccinated adults attending community testing locations in the netherlands from june 2021 till february 2022 |
| url | https://doi.org/10.1371/journal.pone.0311229 |
| work_keys_str_mv | AT claudialaarman sarscov2riskfactorsamongsymptomaticvaccinatedadultsattendingcommunitytestinglocationsinthenetherlandsfromjune2021tillfebruary2022 AT susanjhahne sarscov2riskfactorsamongsymptomaticvaccinatedadultsattendingcommunitytestinglocationsinthenetherlandsfromjune2021tillfebruary2022 AT hesteredemelker sarscov2riskfactorsamongsymptomaticvaccinatedadultsattendingcommunitytestinglocationsinthenetherlandsfromjune2021tillfebruary2022 AT mirjamjknol sarscov2riskfactorsamongsymptomaticvaccinatedadultsattendingcommunitytestinglocationsinthenetherlandsfromjune2021tillfebruary2022 |